ATE123066T1 - Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten. - Google Patents

Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.

Info

Publication number
ATE123066T1
ATE123066T1 AT89903892T AT89903892T ATE123066T1 AT E123066 T1 ATE123066 T1 AT E123066T1 AT 89903892 T AT89903892 T AT 89903892T AT 89903892 T AT89903892 T AT 89903892T AT E123066 T1 ATE123066 T1 AT E123066T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
mucin
hybridoma cells
synthetic
gluciden
Prior art date
Application number
AT89903892T
Other languages
English (en)
Inventor
Thomas J The Biomembr Kjeldsen
Henrik The Biomembrane Clausen
Anil The Biomembrane I Singhai
Tatsushi The Biomembr Toyokuni
Helio The Biomembran Takahashi
Sen-Itiroh The Biomem Hakomori
Original Assignee
Biomembrane Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomembrane Inst filed Critical Biomembrane Inst
Application granted granted Critical
Publication of ATE123066T1 publication Critical patent/ATE123066T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018—Lipids, e.g. in lipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT89903892T 1988-03-11 1989-03-10 Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten. ATE123066T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16778688A 1988-03-11 1988-03-11
US31749289A 1989-03-01 1989-03-01

Publications (1)

Publication Number Publication Date
ATE123066T1 true ATE123066T1 (de) 1995-06-15

Family

ID=26863475

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89903892T ATE123066T1 (de) 1988-03-11 1989-03-10 Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.

Country Status (6)

Country Link
EP (1) EP0357767B1 (de)
JP (2) JP2849683B2 (de)
AT (1) ATE123066T1 (de)
CA (1) CA1340587C (de)
DE (1) DE68922806T2 (de)
WO (1) WO1989008711A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU653141B2 (en) * 1990-01-26 1994-09-22 Bay Development Corporation Sa Medicaments and methods for treating acquired immune deficiency syndrome (AIDS) and aids-related complex (ARC) employing anti-carbohydrate antibodies and carbohydrate antigens
IE914075A1 (en) * 1990-11-23 1992-06-03 Gen Hospital Corp Inhibition of cell adhesion protein-carbohydrate¹interactions
US5876716A (en) * 1991-01-24 1999-03-02 Bay Development Corporation Sa Method of using an antibody to the TN antigen for the inhibition of HIV infection
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
US5527891A (en) * 1994-03-09 1996-06-18 Biomira, Inc. Stereodirected process for synthesis of α-N-acetylgalactosaminides
US8021667B2 (en) 1994-11-16 2011-09-20 Macfarlane Burnet Institute For Medical Research And Public Health Ltd Compositions for immunotherapy and uses thereof
US6548643B1 (en) * 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
ES2322212T3 (es) 1997-09-29 2009-06-17 The Macfarlane Burnet Institute For Medical Research And Public Health Ltd Composicion de antigeno y linea celular que lleva el receptor manosa.
GB9904695D0 (en) * 1999-03-01 1999-04-21 Imp Cancer Res Tech Peptide
WO2000060229A1 (fr) 1999-04-06 2000-10-12 Mitsubishi Jidosha Kogyo Kabushiki Kaisha Dispositif anti-pollution pour moteurs thermiques
KR102262720B1 (ko) 2014-04-28 2021-06-08 이카가쿠 소우야쿠 가부시키가이샤 항muc1 항체 또는 그의 항원 결합성 단편 및 그 용도
CN111630069B (zh) * 2017-10-13 2024-05-31 勃林格殷格翰国际有限公司 针对Thomsen-nouvelle(Tn)抗原的人抗体
US11161911B2 (en) 2017-10-23 2021-11-02 Go Therapeutics, Inc. Anti-glyco-MUC1 antibodies and their uses
PT110526B (pt) * 2018-01-26 2021-02-04 Univ Nova De Lisboa Anticorpo, fragmento funcional ou sonda do mesmo contra antigénios tumorais

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444744A (en) * 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens

Also Published As

Publication number Publication date
JP3066741B2 (ja) 2000-07-17
JPH1192400A (ja) 1999-04-06
JP2849683B2 (ja) 1999-01-20
EP0357767A1 (de) 1990-03-14
JPH02503387A (ja) 1990-10-18
DE68922806D1 (de) 1995-06-29
EP0357767A4 (en) 1990-09-05
CA1340587C (en) 1999-06-08
WO1989008711A1 (en) 1989-09-21
DE68922806T2 (de) 1996-02-29
EP0357767B1 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
ATE123066T1 (de) Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten.
DK1375520T3 (da) Apoptose induceret af monoklonalt antistof anti-Her2
DE69536072D1 (de) CDR-ausgetauschte Typ III Anti-CEA humanisierte monoklonale Mausantikörper
JPS6447378A (en) Monoclonal antibody to black tumor related antigen, hybrid cell line for producing the same and use thereof
DE68924773D1 (de) Monoklonale antikörper gegen den bereich der leichten kette von menschlichem faktor xii sowie methoden zu deren herstellung und verwendung.
ATE14899T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches monozytantigen, antikoerper und verfahren.
BR0208676A (pt) anticorpo monoclonal quimérico, linhagem celular, composição farmacêutica, e, uso de um anticorpo monoclonal
DE3650032D1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
JPS6463393A (en) Monoclonal antibody
ATE285417T1 (de) Herstellung von antikörpern
NZ329314A (en) Hybridoma & method of preparing a monoclonal antibody reactive with hc gp-39, use & treatment of rheumatoid arthritis
JPS6468398A (en) Monoclonal anti-idiotype antibody and hybridoma and use thereof
ATE110109T1 (de) Monoklonaler antikörper gegen kern-hcg-beta, seine herstellung und verwendung.
ATE283927T1 (de) Monoklonale antikörper und antigene mit bezug zum menschlichen lungenadenokarzinom und immunoassay- verfahren unter verwendung desselben
EP0131878A3 (de) Verfahren zur Herstellung menschlicher monoklonaler Antikörper
DE59410219D1 (de) Monoklonale antikörper gegen ck-mb
EP0155172A3 (de) Monoklonale Antikörper gegen menschlichen Lungenkrebs
Mahana et al. Mice ascites as a source of polyclonal and monoclonal antibodies
ATE187463T1 (de) Monoklonale antikörper gegen tumorassoziierte antigene, verfahren zu ihrer herstellung und ihre verwendung
ATE125305T1 (de) Monoklonale antikörper von ratten gegen menschliche antigene und verfahren zu deren herstellung.
JPH03206894A (ja) 新規抗イディオタイプモノクローナル抗体
Yermakov et al. Monoclonal IgG antibodies against Shigella flexneri VI LPS.
KR960701987A (ko) 단일클론 항체 88bv59, 서브클론 및 이들의 제조 방법(monoclonal antibody 88bv59, subclones and method of making)
JPH03279400A (ja) モノクローナル抗体の作製方法
JPS6443199A (en) Monoclonal antibody 4c1 to human cancerous cell and hybridoma capable of producing said antibody

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee